Bernard P - Search Results

1

The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index.

Allard P, Bernard P, Fradet Y, Têtu B. Allard P, et al. Among authors: bernard p. Br J Urol. 1998 May;81(5):692-8. doi: 10.1046/j.1464-410x.1998.00628.x. Br J Urol. 1998. PMID: 9634043

2

Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.

Allard P, Fradet Y, Têtu B, Bernard P. Allard P, et al. Among authors: bernard p. Clin Cancer Res. 1995 Oct;1(10):1195-202. Clin Cancer Res. 1995. PMID: 9815912

3

Prevalence and clinical significance of HER/2neu, p53 and Rb expression in primary superficial bladder cancer.

Tetu B, Fradet Y, Allard P, Veilleux C, Roberge N, Bernard P. Tetu B, et al. Among authors: bernard p. J Urol. 1996 May;155(5):1784-8. J Urol. 1996. PMID: 8627884

4

Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancer.

Têtu B, Allard P, Fradet Y, Roberge N, Bernard P. Têtu B, et al. Among authors: bernard p. Hum Pathol. 1996 Sep;27(9):922-6. doi: 10.1016/s0046-8177(96)90219-1. Hum Pathol. 1996. PMID: 8816887

5

Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer.

Têtu B, Brisson J, Lapointe H, Bernard P. Têtu B, et al. Among authors: bernard p. Hum Pathol. 1998 Sep;29(9):979-85. doi: 10.1016/s0046-8177(98)90204-0. Hum Pathol. 1998. PMID: 9744315

6

p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer.

Têtu B, Brisson J, Plante V, Bernard P. Têtu B, et al. Among authors: bernard p. Mod Pathol. 1998 Sep;11(9):823-30. Mod Pathol. 1998. PMID: 9758361

7

Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases.

Têtu B, Brisson J, Lapointe H, Wang CS, Bernard P, Blanchette C. Têtu B, et al. Among authors: bernard p. Breast Cancer Res Treat. 1999 May;55(2):137-47. doi: 10.1023/a:1006140213493. Breast Cancer Res Treat. 1999. PMID: 10481941

8

How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial.

Allard P, Lamontagne C, Bernard P, Tremblay C. Allard P, et al. Among authors: bernard p. J Pain Symptom Manage. 1999 Apr;17(4):256-65. doi: 10.1016/s0885-3924(98)00157-2. J Pain Symptom Manage. 1999. PMID: 10203878 Free article. Clinical Trial.

9

Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease.

St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Bernard PM, Després JP, Lamarche B. St-Pierre AC, et al. Among authors: bernard pm. Circulation. 2001 Nov 6;104(19):2295-9. doi: 10.1161/hc4401.098490. Circulation. 2001. PMID: 11696468

10

PSA screening and prostate cancer mortality.

Perron L, Moore L, Bairati I, Bernard PM, Meyer F. Perron L, et al. CMAJ. 2002 Mar 5;166(5):586-91. CMAJ. 2002. PMID: 11898936 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,885 results

Search Page

Filters